Geode Capital Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.9M | Buy |
1,339,405
+322,063
| +32% | +$2.36M | ﹤0.01% | 2491 |
|
|
2026
Q1 | $6.5M | Buy |
1,017,342
+22,997
| +2% | +$148K | ﹤0.01% | 2614 |
|
|
2025
Q4 | $5.92M | Buy |
994,345
+10,823
| +1% | +$57.5K | ﹤0.01% | 2681 |
|
|
2025
Q3 | $5.22M | Buy |
983,522
+11,848
| +1% | +$50.2K | ﹤0.01% | 2754 |
|
|
2025
Q2 | $3.33M | Buy |
971,674
+16,218
| +2% | +$51.8K | ﹤0.01% | 2940 |
|
|
2025
Q1 | $2.83M | Buy |
955,456
+36,021
| +4% | +$113K | ﹤0.01% | 2917 |
|
|
2024
Q4 | $2.8M | Buy |
919,435
+2,068
| +0.2% | +$6.02K | ﹤0.01% | 3016 |
|
|
2024
Q3 | $2.34M | Sell |
917,367
-32,779
| -3% | -$99.2K | ﹤0.01% | 3072 |
|
|
2024
Q2 | $3.1M | Buy |
950,146
+497,175
| +110% | +$2.18M | ﹤0.01% | 2968 |
|
|
2024
Q1 | $2.4M | Buy |
452,971
+8,925
| +2% | +$48.1K | ﹤0.01% | 3048 |
|
|
2023
Q4 | $1.92M | Buy |
444,046
+18,531
| +4% | +$61.4K | ﹤0.01% | 3113 |
|
|
2023
Q3 | $1.12M | Buy |
425,515
+29,119
| +7% | +$99.2K | ﹤0.01% | 3274 |
|
|
2023
Q2 | $1.4M | Buy |
396,396
+4,774
| +1% | +$14.9K | ﹤0.01% | 3229 |
|
|
2023
Q1 | $1.21M | Buy |
391,622
+10,711
| +3% | +$40.4K | ﹤0.01% | 3260 |
|
|
2022
Q4 | $1.61M | Buy |
380,911
+6,245
| +2% | +$21.5K | ﹤0.01% | 3142 |
|
|
2022
Q3 | $887K | Buy |
374,666
+4,575
| +1% | +$13.4K | ﹤0.01% | 3447 |
|
|
2022
Q2 | $1.05M | Sell |
370,091
-229,323
| -38% | -$570K | ﹤0.01% | 3396 |
|
|
2022
Q1 | $1.73M | Sell |
599,414
-37,878
| -6% | -$98K | ﹤0.01% | 3330 |
|
|
2021
Q4 | $1.94M | Buy |
637,292
+30,141
| +5% | +$131K | ﹤0.01% | 3379 |
|
|
2021
Q3 | $4.26M | Sell |
607,151
-13,975
| -2% | -$105K | ﹤0.01% | 3004 |
|
|
2021
Q2 | $5.7M | Buy |
621,126
+18,738
| +3% | +$190K | ﹤0.01% | 2817 |
|
|
2021
Q1 | $5.86M | Buy |
602,388
+76,049
| +14% | +$849K | ﹤0.01% | 2712 |
|
|
2020
Q4 | $5.4M | Sell |
526,339
-11,546
| -2% | -$117K | ﹤0.01% | 2561 |
|
|
2020
Q3 | $5.43M | Buy |
537,885
+10,870
| +2% | +$111K | ﹤0.01% | 2341 |
|
|
2020
Q2 | $5.5M | Buy |
527,015
+54,578
| +12% | +$565K | ﹤0.01% | 2288 |
|
|
2020
Q1 | $3.99M | Sell |
472,437
-93,606
| -17% | -$909K | ﹤0.01% | 2270 |
|
|
2019
Q4 | $4.95M | Buy |
566,043
+163,303
| +41% | +$1.35M | ﹤0.01% | 2461 |
|
|
2019
Q3 | $4.33M | Buy |
402,740
+8,128
| +2% | +$87.8K | ﹤0.01% | 2464 |
|
|
2019
Q2 | $5.01M | Buy |
394,612
+25,692
| +7% | +$592K | ﹤0.01% | 2389 |
|
|
2019
Q1 | $14.3M | Buy |
368,920
+33,051
| +10% | +$1.01M | ﹤0.01% | 1646 |
|
|
2018
Q4 | $6.83M | Buy |
335,869
+11,840
| +4% | +$355K | ﹤0.01% | 2032 |
|
|
2018
Q3 | $14.9M | Buy |
324,029
+19,396
| +6% | +$935K | ﹤0.01% | 1627 |
|
|
2018
Q2 | $18M | Buy |
304,633
+6,276
| +2% | +$364K | 0.01% | 1434 |
|
|
2018
Q1 | $20.3M | Buy |
298,357
+7,666
| +3% | +$574K | 0.01% | 1250 |
|
|
2017
Q4 | $28.7M | Buy |
290,691
+7,772
| +3% | +$870K | 0.01% | 1004 |
|
|
2017
Q3 | $33.9M | Buy |
282,919
+24,379
| +9% | +$2.27M | 0.01% | 886 |
|
|
2017
Q2 | $22.6M | Buy |
258,540
+26,169
| +11% | +$1.46M | 0.01% | 1086 |
|
|
2017
Q1 | $8.64M | Buy |
232,371
+34,190
| +17% | +$1.25M | ﹤0.01% | 1717 |
|
|
2016
Q4 | $6.08M | Buy |
198,181
+26,490
| +15% | +$1.15M | ﹤0.01% | 1928 |
|
|
2016
Q3 | $11.5M | Buy |
171,691
+24,741
| +17% | +$1.25M | 0.01% | 1402 |
|
|
2016
Q2 | $4.38M | Buy |
146,950
+17,015
| +13% | +$532K | ﹤0.01% | 2007 |
|
|
2016
Q1 | $3.82K | Buy |
129,935
+2,773
| +2% | +$125K | ﹤0.01% | 2045 |
|
|
2015
Q4 | $9.97M | Buy |
127,162
+5,382
| +4% | +$422K | 0.01% | 1388 |
|
|
2015
Q3 | $9.17M | Sell |
121,780
-4,256
| -3% | -$402K | 0.01% | 1405 |
|
|
2015
Q2 | $14.7M | Sell |
126,036
-8,592
| -6% | -$1.56M | 0.01% | 1147 |
|
|
2015
Q1 | $31.8M | Buy |
134,628
+11,233
| +9% | +$2.4M | 0.02% | 680 |
|
|
2014
Q4 | $23.4M | Buy |
123,395
+760
| +0.6% | +$169K | 0.01% | 772 |
|
|
2014
Q3 | $29.3M | Buy |
122,635
+5,370
| +5% | +$1.1M | 0.02% | 656 |
|
|
2014
Q2 | $7.74M | Buy |
117,265
+364
| +0.3% | +$25.9K | 0.01% | 1496 |
|
|
2014
Q1 | $12.2M | Buy |
116,901
+14,508
| +14% | +$1.71M | 0.01% | 1107 |
|
|
2013
Q4 | $10.6M | Buy |
102,393
+1,299
| +1% | +$76.2K | 0.01% | 1146 |
|
|
2013
Q3 | $5.42M | Buy |
101,094
+60,479
| +149% | +$3.26M | ﹤0.01% | 1499 |
|
|
2013
Q2 | $1.8M | Buy |
+40,615
| New | +$1.43M | ﹤0.01% | 2109 |
|
Other funds holding PBYI
ACA
OSAM
Geode Capital Management's PBYI Position: Q2 2026 in Review
Geode Capital Management increased its Puma Biotechnology (PBYI) stake by 32% in Q2 2026, buying an estimated $2.36M and bringing the position to 1,339,405 shares worth $10.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2491.
Geode Capital Management first reported a position in PBYI in Q2 2013 and has held it in 53 quarters since. The position peaked at $33.9M in Q3 2017. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.
- Geode Capital Management held 1,339,405 shares of Puma Biotechnology worth $10.9M as of Q2 2026.
- Geode Capital Management bought 322,063 Puma Biotechnology shares in Q2 2026, an estimated $2.36M.
- Puma Biotechnology made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2491 holding.
- Geode Capital Management first reported a position in Puma Biotechnology in Q2 2013 and has held it in 53 quarters since.
- Geode Capital Management's Puma Biotechnology position peaked at $33.9M in Q3 2017.
- 161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.